Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2.

Saved in:
Bibliographic Details
Title: Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2.
Authors: Kuczynski LE; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Shallow JR; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Watson MP; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Homsy ML; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Svab T; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Gruber A; Analytical Research & Development, MRL, Merck & Co., Inc, West Point, Pennsylvania, USA., Rustandi RR; Analytical Research & Development, MRL, Merck & Co., Inc, West Point, Pennsylvania, USA., Hu J; Center of Mathematical Sciences, MMD, Merck & Co., Inc., West Point, Pennsylvania, USA., Winters MA; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.
Source: Biotechnology journal [Biotechnol J] 2024 Jan; Vol. 19 (1), pp. e2300041. Date of Electronic Publication: 2023 Oct 10.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 101265833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7314 (Electronic) Linking ISSN: 18606768 NLM ISO Abbreviation: Biotechnol J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1860-7314
DOI:10.1002/biot.202300041